COVID-19 Clinical Trials in Houston

Showing 1-20 of 197 trials

The Effect of COVID-19 Pandemic on Adolescent and Young Adult Cancer Patients and Survivors

NCT04551378

The study investigates how the COVID-19 pandemic has impacted the psychological, financial, physical, and social well-being of adolescent and young adult (AYA) cancer patients and survivors. AYA cancer survivors have inferior long-term survival compared to the general population, and the negative impact of the global COVID-19 pandemic may be even higher in this vulnerable group. The information gained from this study may provide an opportunity to determine the self-reported COVID-19 specific psychological distress in AYA cancer survivors, and may lead to the development of a targeted intervention to improve physical and psychosocial health for AYA cancer patients and survivors.

COVID-19 InfectionHematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm

M.D. Anderson Cancer Center600 participantsStarted Jul 2020

Houston, Texas, United States

COMPLETEDPhase 3< 1 mile

A Study of mRNA-1283 Injection Compared With mRNA-1273 Injection in Participants ≥12 Years of Age to Prevent COVID-19

NCT05815498

The purpose of this study (Part 1 and Part 2) is to evaluate the relative vaccine efficacy (rVE), safety, reactogenicity, and immunogenicity of mRNA-1283.222 versus mRNA-1273.222 (Part 1) and mRNA-1283.815 versus mRNA-1273.815 (Part 2).

COVID-19

ModernaTX, Inc.13,553 participantsStarted Mar 2023

Huntsville, Alabama, United States • Vestavia Hills, Alabama, United States • Chandler, Arizona, United States +227 more locations

The Effect of COVID-19 Pandemic on Adolescent and Young Adult Cancer Patients and Survivors

A Study of mRNA-1283 Injection Compared With mRNA-1273 Injection in Participants ≥12 Years of Age to Prevent COVID-19

COVID-19 Trials in Other Cities

Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock Out Virus Specific CTL Lines for Viral Infections in Immunosuppressed Cancer Patients

Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia

A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children

Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals

I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients

Study of VYD2311 for the Prevention of COVID-19

A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease

The Impact of COVID-19 on Pulmonary Procedures

A Study to Learn About BNT162b2 (LP.8.1)-Adapted Vaccine Against SARS-CoV-2 in Children 5 Through 11 Years of Age That Are Considered at Higher Risk of Severe COVID-19

Assessment of the Psychosocial Impact of the COVID-19 Pandemic on the MD Anderson Cancer Center Workforce

Understanding the Long-term Impact of COVID on Children and Families

A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age

Safety and Immunogenicity of NVX-CoV2705

Reparixin add-on Therapy to Standard Care to Limit Progression in Pts With COVID19 & Other Community Acquired Pneumonia

Outpatient Treatment With Anti-Coronavirus Immunoglobulin

NE3107 in Adults With Neurological Symptoms of Long COVID

Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID

Evaluation of COVID-19 and Flu A/B 3 in 1 Combo Rapid Test

Other Conditions in Houston